Bond Screener
Illumina
LEI SQ95QG8SR5Q56LSNF682
Organization name
Illumina Inc
Country name
USA
Country of registration
USA
Industry
Medical Devices
Credit Ratings
in foreign currency
Public debt
1,800 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Illumina, Inc. (Illumina) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function. The Company provides a line of genetic analysis solutions, with products and services that serve a range of interconnected markets, including sequencing, genotyping, gene expression, and molecular diagnostics. The Company is organized in two business segments: Life Sciences and Diagnostics. Its Life Sciences business unit includes all products and services related to the research market, namely the product lines based on its sequencing, BeadArray, VeraCode, and real-time PCR technologies. Its Diagnostics business unit focuses on molecular diagnostics. Its customers include genomic research centres, academic institutions, government laboratories, and clinical research organizations.
|
General information
-
Organization nameIllumina Inc
-
Organization statusOperating organization
-
Address5200 Illumina Way, San Diego, USA, 92122
-
Site
News
-
UBS Upgrades Illumina to Buy from Neutral10/09/2026
-
Should You Add Illumina Stock to Your Portfolio Now?28/08/2026
-
Illumina: Entry Into A Material Definitive Agreement, Termination Of A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of A Registrant, Exhibits13/08/2026
-
BMRN vs. ILMN: Which Stock Is the Better Value Option?12/08/2026
-
New issue: Illumina issued international bonds (US452327AS80) with the coupon rate of 4.95% in the amount of USD 300 mln maturing in 202911/08/2026
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show more
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameIllumina Inc
-
Organization statusOperating organization
-
Address5200 Illumina Way, San Diego, USA, 92122
-
Site
Codes
-
LEISQ95QG8SR5Q56LSNF682
-
SIC3826 LABORATORY ANALYTICAL INSTRUMENTS
-
ICB4,500 Health Care
-
NACE*** ***
-
NAICS*** ***
-
CIK0001110803
-
EIN33-0804655
